|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenues | ||||
| Cost of revenues | ||||
| Gross Profit/(loss) | ||||
| Sales and marketing expenses | ||||
| General and administrative expenses | ||||
| Research and development expenses | ||||
| Impairment of long-lived assets | ||||
| Impairment losses of assets | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Other income/(expense), net | ||||
| Loss before income tax | ||||
| Net loss | ||||
| Other comprehensive loss | ||||
| Foreign currency translation (loss )/gain | ||||
| Total comprehensive loss | ||||
| Loss per ordinary share* | ||||
| Basic (in Dollars per share) | ||||
| Diluted (in Dollars per share) | ||||
| Weighted average number of ordinary shares outstanding*: | ||||
| Basic (in Shares) | ||||
| Diluted (in Shares) |
Loading...